India’s patent office “has rejected American drug maker Abbott Laboratories’ patent application for an HIV combination drug, allowing low-cost local drug makers to make and sell their generic versions in India and other countries where the medicine is not patented,” Economic Times reports (1/4). The drug under consideration was Abbott’s “Kaletra, which combines two antivirals, [lopinavir/ritonavir and] is one of the preferred second-line treatments to fight drug-resistant HIV, according to the World Health Organization, which recommends governments include it on their list of essential medicines,” Bloomberg/Businessweek writes (Narayan, 1/4).
Also In Global Health News: Field Trial To Fight Dengue In Australia; Bangladesh Reducing Child Mortality; Yellow Fever In Uganda; HIV/AIDS In Iran
Dengue-Blocking Mosquitoes Field Trial To Kick Off Tuesday In Australia AAP/Sydney Morning Herald reports that a 12-week field trial involving the release of mosquitoes infected with a bacterium known to block the transmission of dengue will kick off Tuesday in several suburbs in north Queensland, Australia. “Laboratory research has shown…
MedPage Today examines recent HIV prevention developments, in a 2010 year in review piece, beginning with the announcement at the International AIDS Conference in July that a microbicide gel used by women before and after sex reduced HIV infection by 39 percent.
Also In Global Health News: Water In The Philippines; Potential HIV Treatment; Kenyan Food Security; TB In Prisons; Ethiopian HIV Plan
Government Agencies In The Philippines Sign Sanitation Agreement To Expand Clean Water Access Filipino Interior and Local Government Secretary Jesse Robredo, Health Secretary Enrique Ona, and National Anti-Poverty Commission Secretary General Jose Eliseo Rocamora signed an agreement to honor the President’s Priority Program on Water (P3W), the Manila Bulletin reports.…
The Problem With A ‘Robo Budget’: In a post on “The Hill’s Congress Blog,” Senator Patrick Leahy, (D-Vt.), writes about the recent defeat of the omnibus bill, calling the passage of a continuing resolution a “robo budget” that is a “disservice.” According to Leahy: “The Omnibus would have funded global…
“The Vatican on Tuesday issued its most authoritative clarification on Pope Benedict XVI’s recent remarks that condoms could sometimes be used for disease prevention, saying that the pope in no way justified their use to prevent pregnancy,” the New York Times reports (Donadio, 12/21).
The New York Times examines the Bill & Melinda Gates Foundation’s Grand Challenges in Global Health program, which gave a total of $450 million to 43 research projects over five years. “On drawing attention to ways that lives might be saved through scientific advances, I’d give us an A,” Bill Gates, co-founder of the foundation, said of the program in an interview with the newspaper. “But I thought some would be saving lives by now, and it’ll be more like in 10 years from now,” Gates said.
Also In Global Health News: Disabled People And HIV; HIV/AIDS In Cambodia; South Africa Global Fund Grant; Early Marriage In Zambia; Indian Health Deal In Rwanda
U.N. Agencies’ Efforts To Combat HIV/AIDS Among Disabled People Examined IRIN PlusNewsÂ reports on different efforts aimed at addressing HIV/AIDS among people living with disabilities. “More than 600 million peopleÂ â€“ 10 percent of the global populationÂ â€“ live with disabilities, and 80 percent of them live in developing countries. This population often…
The Citizen/allAfrica.com Examines Potential Impact Of EU-India Free Trade Agreement On HIV/AIDS Patients In Developing Countries
The Citizen/allAfrica.com examines the potential impact a free-trade agreement between the EU and India currently under negotiation could have on patients living with HIV/AIDS in developing countries.
Here is a sampling of blog posts analyzingÂ theÂ Quadrennial Diplomacy and Development Review (QDDR) after it was released on Wednesday: Council on Foreign Relations: Weighing an Ambitious QDDR (Garrett et al., 12/16); CGD’s “Rethinking U.S. Foreign Assistance Blog”: The QDDR: Whew, Itâ€™s Done (Or Is It?) (Veillette, 12/16); State Department’s…